Your browser is no longer supported. Please, upgrade your browser.
Settings
VRX Valeant Pharmaceuticals International, Inc. daily Stock Chart
VRX [NYSE]
Valeant Pharmaceuticals International, Inc.
Index- P/E- EPS (ttm)-2.14 Insider Own2.30% Shs Outstand346.84M Perf Week-0.76%
Market Cap7.72B Forward P/E2.82 EPS next Y7.90 Insider Trans2.60% Shs Float332.87M Perf Month-14.78%
Income-739.10M PEG- EPS next Q1.61 Inst Own66.80% Short Float7.89% Perf Quarter-28.43%
Sales10.63B P/S0.73 EPS this Y-133.00% Inst Trans20.28% Short Ratio0.80 Perf Half Y-80.33%
Book/sh16.40 P/B1.36 EPS next Y18.64% ROA-1.50% Target Price51.11 Perf Year-90.29%
Cash/sh3.78 P/C5.89 EPS next 5Y7.70% ROE-12.10% 52W Range21.40 - 263.81 Perf YTD-78.11%
Dividend- P/FCF3.84 EPS past 5Y4.40% ROI3.70% 52W High-92.32% Beta0.24
Dividend %- Quick Ratio1.10 Sales past 5Y54.60% Gross Margin75.20% 52W Low-5.28% ATR1.54
Employees22000 Current Ratio1.40 Sales Q/Q9.30% Oper. Margin9.90% RSI (14)29.48 Volatility4.98% 5.60%
OptionableYes Debt/Eq5.65 EPS Q/Q-480.80% Profit Margin-7.00% Rel Volume0.84 Prev Close22.25
ShortableYes LT Debt/Eq5.54 EarningsJun 07 BMO Payout- Avg Volume32.71M Price20.27
Recom2.90 SMA20-19.40% SMA50-29.13% SMA200-75.94% Volume27,357,401 Change-8.90%
Jun-23-16Downgrade JP Morgan Overweight → Neutral
Jun-08-16Reiterated Stifel Buy $65 → $55
Jun-08-16Reiterated RBC Capital Mkts Sector Perform $58 → $33
Jun-08-16Reiterated Mizuho Underperform $18 → $11
May-03-16Reiterated Rodman & Renshaw Buy $105 → $102
Apr-12-16Reiterated RBC Capital Mkts Sector Perform $69 → $65
Apr-11-16Reiterated Rodman & Renshaw Buy $118 → $105
Mar-21-16Downgrade Mizuho Neutral → Underperform $70 → $18
Mar-21-16Downgrade Barclays Overweight → Equal Weight $135 → $34
Mar-16-16Reiterated Stifel Buy $200 → $65
Mar-16-16Reiterated Rodman & Renshaw Buy $150 → $118
Mar-16-16Reiterated RBC Capital Mkts Sector Perform $85 → $69
Mar-16-16Reiterated Canaccord Genuity Hold $75 → $40
Mar-16-16Downgrade Nomura Buy → Neutral $175 → $60
Mar-16-16Downgrade CIBC Sector Perform → Sector Underperform
Mar-15-16Downgrade Piper Jaffray Neutral → Underweight
Mar-08-16Reiterated Mizuho Neutral $112 → $70
Mar-02-16Downgrade Canaccord Genuity Buy → Hold $125 → $75
Mar-01-16Downgrade RBC Capital Mkts Outperform → Sector Perform $194 → $85
Feb-29-16Downgrade TD Securities Buy → Hold
Jun-24-16 04:04PM  British Banks Top Fridays 52-Week Low Club at 24/7 Wall St. -8.90%
01:30PM  This Merger Could Mean Returns Of Up To 40%
Jun-23-16 04:42PM  Better Buy: Valeant Pharmaceuticals International, Inc. vs. Allergan at Motley Fool
04:13PM  Valeant Gets Credit Downgrade As Recovery Slower Than Hoped
04:04PM  Valeant Returns in Thursdays 52-Week Low Club at 24/7 Wall St.
01:58PM  ETFs with exposure to Valeant Pharmaceuticals International, Inc. : June 23, 2016
11:15AM  Valeant Pharmaceuticals: Now You Downgrade It? at Barrons.com
10:28AM  Forget a 'Flash Crash'; How About a 'Flash Squeeze' Instead?
10:06AM  Valeant Pharmaceuticals (VRX) Stock Rating Downgraded at JPMorgan
09:17AM  3 Stocks That Have Been Cut in Half This Year at Motley Fool
09:01AM  Tesla, SolarCity and the Race to the Bottom
06:20AM  Valeant Pharma downgraded by JP Morgan
Jun-22-16 07:41PM  New Valeant Accounting Chief is Early Step in Overhaul at The Wall Street Journal
12:16PM  Valeant Enlists Former Tyco Exec for More Help With Accounting
12:14PM  Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016
08:52AM  Research Report Initiated on Select Healthcare Equities
07:07AM  CFO Moves: Taro Pharmaceutical, Valeant at The Wall Street Journal
04:04AM  What Do Analysts Think about Valeant?
Jun-21-16 06:45PM  Valeant Pharma names Eldessouky accounting chief at MarketWatch
05:18PM  Bill Ackman Is Gearing Up for Another Campaign Against Herbalife at Fortune
05:03PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers
03:04PM  JetBlue Joins Valeant in Tuesdays 52-Week Low Club at 24/7 Wall St.
Jun-20-16 06:34PM  A new way to cut drug prices? Make Big Pharma show what it spends to bring drugs to market at Los Angeles Times
04:04PM  Valeant Once More Makes Mondays 52-Week Low Club at 24/7 Wall St.
03:15PM  Moody's: Liquidity-Stress Index improves but risks prevail at Moody's
07:58AM  Morning Movers: CHK, FCX, CCL, DIS, VRX
04:46AM  Calls For Actions Grow Louder
Jun-19-16 10:05AM  Buffett and Top Hedge Funds Continue Massive Insider Buying: Phillips 66, Advanced Auto Parts, Lands End, Valeant Pharmaceuticals and More at 24/7 Wall St.
05:08AM  [$$] Deutsche aims to raise ?1bn from socially responsible products at Financial Times
Jun-17-16 04:04PM  Valeant, American Airlines Repeat in Fridays 52-Week Low Club at 24/7 Wall St.
02:41PM  How Much Is Valeant Pharmaceuticals Really Worth? at Motley Fool
10:01AM  Is Valeant Stock a Safe Short?
08:45AM  Early movers: LL, VIAB, ORCL, SWHC, FNSR, REV, VRX at CNBC
08:14AM  Valeant to invest $27.5 million in its Canadian manufacturing facilities at MarketWatch
08:00AM  Valeant Pharmaceuticals Announces Significant Investments In Canadian Operations PR Newswire
08:00AM  Valeant Pharmaceuticals Announces Significant Investments In Canadian Operations CNW Group
07:42AM  9 Easy Ways to Lose Money in the Stock Market at Motley Fool
07:00AM  Allergan Carves Middle Path In R&D Spending With 'Open Science'
Jun-16-16 04:04PM  Valeant, American Airlines, Cavium in Thursdays 52-Week Low Club at 24/7 Wall St. -5.24%
02:50PM  Debt-Burdened Valeant Must Shed Assets, Analysts Say
01:08PM  Trending Tickers: KR, PXD, M, YHOO, VRX
12:48PM  Valeant 'Up Against the Wall,' Must Sell Assets, Analysts Say
12:31PM  Why Traders Are Buzzing about These Stocks: Yahoo, Alibaba, and More at Insider Monkey
09:22AM  The C-Suite Speaks: Views from the Top and the Bottom
08:31AM  Should You Get Rid of Valeant Pharmaceuticals (VRX) Now?
08:15AM  Billionaires Are Turning Away from These Five Stocks at Insider Monkey
08:00AM  Valeant Pharmaceuticals Announces Launch Of New PreserVision® AREDS 2 Formula + Multivitamin PR Newswire
08:00AM  Valeant Pharmaceuticals Announces Launch Of New PreserVision® AREDS 2 Formula + Multivitamin CNW Group
06:57AM  Valeant Falls As Barclays Sees 'No Short-Term Fix' (VRX, WBA) at Investopedia
06:00AM  Jim Cramer's Top Takeaways: AT&T, Nexstar Broadcasting, Valeant, Ollie's
Jun-15-16 07:25PM  CEO of Valeant Joseph Papa Makes $5 Million Insider Buy
06:46PM  Cramer on Valeant: New CEO, but it's still rotten at the core at CNBC
04:23PM  Beleaguered Valeant Appoints Lead Independent Director
03:49PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
03:08PM  Ackman's Pershing Square Buys Valeant Insurance (VRX, PSHZF) at Investopedia
03:06PM  3 Beaten-Up Healthcare Stocks: Are They Bargains? at Motley Fool
01:48PM  Insiders Are Scooping Up Shares of These 5 Stocks
12:53PM  Valeant (VRX) Stock Slides, Barclays: 'No Short-Term Fix'
12:26PM  Are Papa's Plans to Rebuild Valeant Concrete Enough?
11:01AM  Valeant Pharmaceuticals: No Short-Term Fix? at Barrons.com
08:08AM  Valeant appoints Thomas Ross as lead independent director at MarketWatch
08:00AM  Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent Director PR Newswire
08:00AM  Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent Director CNW Group
Jun-14-16 06:04PM  Edward Jones' Fehr: Valeant Still a Wait-and-See Story
04:55PM  Valeant's New CEO Bought Shares -- Should You Too? at Motley Fool
01:55PM  Rationale For Ragamuffins at Forbes
12:10PM  Papa Leaves Valeant Investors With More Questions
12:09PM  Valeant Holds a Shareholder Meeting, and Nothing Goes Wrong at Bloomberg
11:43AM  Valeant CEO open to selling core assets if price is right Reuters
11:20AM  Valeant CEO reiterates plans to rebuild embattled company at CNBC
11:13AM  A few random shareholders just made the Valeant CEO sound stumped in less than 20 minutes
10:10AM  Company News for June 14, 2016
10:04AM  Valeant CEO Joe Papa Outlines Turnaround Plan
10:03AM  Valeant Shareholders Get Their Say at Annual Meeting at Bloomberg
08:45AM  Valeant Pharmaceuticals Intl Inc. (VRX)s New CEO Buys Massive Block of Shares, Plus Four Other Companies with Noteworthy Insider Activity at Insider Monkey
07:06AM  Valeant's CEO Joseph Papa Buys 202,000 Shares (VRX) at Investopedia
07:00AM  New Valeant CEO meets investors as doubts grow about drug company Reuters
05:39AM  Valeant Hires Morgan Stanley to Sell Dermatology Assets at Bloomberg
Jun-13-16 04:38PM  Valeant shares rise after big CEO stock purchase at CNBC
04:26PM  Valeant Shares Pop on CEO Stock Purchase at TheStreet
02:39PM  Valeant's CEO Bought VRX Shares, But Here's Why You Shouldn't
02:15PM  Why Andrew Left and Citron Are Wrong About Facebook (FB) Stock
02:14PM  Valeant Tries to Fix 'Speed Bumps' in Walgreens Deal
01:32PM  Cramer Isn't Sold That You Should Sell Facebook as Left Predicts
12:14PM  Valeant, Walgreens CEOs to Tackle 'Speed Bumps'
11:56AM  Ackman Pared His Stake in Mondelez International In ast Quarter
10:42AM  Valeant Pharmaceuticals International, Inc. :VRX-CA: Earnings Analysis: Q1, 2016 By the Numbers : June 13, 2016
10:22AM  Valeant Climbs After CEO Buys $4.9M In Shares at Barrons.com
09:41AM  Valeant (VRX) Stock Climbs After CEO Papa Purchased Shares
09:07AM  Why Did Valeant Lower Its Guidance for 2016?
08:37AM  Morning Movers: Valeant Gains on CEO Share Purchase; Steel Dynamics Climbs at Barrons.com
Jun-12-16 02:00PM  Put Agenus, Progenics on Your Small-Cap List
Jun-11-16 06:18PM  Silver Point Capitals Bullish Q1 Moves Include New Stake in Embattled Drugmaker Valeant at Insider Monkey
01:04PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Financials
12:00PM  Index Funds: The Case Against Bill Ackman (STT, BLK) at Investopedia
Jun-10-16 05:12PM  [$$] Week in Review, June 11 at Financial Times -5.26%
03:01PM  The Socially Responsible Investing Boom
02:36PM  The Firm That Called Valeant's Drop
02:12PM  Has Valeant Gone Bottom Fishing?
01:41PM  LPC: Valeant chips away at US$31bn debt burden with US$47.5m repayment Reuters
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Xifaxan for the treatment of irritable bowel syndrome with diarrhea; Wellbutrin XL for major depressive disorder in adults; Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Clindagel, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Glumetza to improve glycemic control in adults with type 2 diabetes mellitus; PROVENGE for the treatment of prostate cancer; and Jublia for onychomycosis of the toenails. It also provides Nitropress for the immediate reduction of blood pressure of patients in hypertensive crises; Isuprel for heart related treatments; Xenazine for chorea; Uceris to get ulcerative colitis under control; Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; Biotrue for healthy contact lens wear; and ReNu Multiplus to lubricate and rewet soft contact lenses. In addition, the company offers Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; various ophthalmic surgical products; SofLens daily disposable contact lenses; Biotrue ONEday lens; Bausch + Lomb Ultra, a contact lens PureVision, a contact lens; and medical device systems for aesthetic applications. Further, it provides Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Metronidazole to treat bacterial infections; and Latanoprost for the treatment of glaucoma. Valeant Pharmaceuticals International, Inc. was founded in 1983 and is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PAPA JOSEPH CCHAIRMAN & CEOJun 10Buy24.48202,0004,944,9602,442,199Jun 13 06:47 AM
Pearson J. MichaelChief Executive OfficerNov 05Sale78.481,297,399101,825,9701,514,664Nov 09 05:24 PM
Farmer Ronald HaroldDirectorOct 21Buy181.601,500272,39515,532Oct 22 05:09 PM
Farmer Ronald HaroldDirectorAug 26Buy220.00500110,0002,000Aug 27 04:33 PM
Farmer Ronald HaroldDirectorAug 21Buy224.971,000224,9731,500Aug 25 04:47 PM
Rosiello Robert L.EVP, Chief Financial OfficerJul 31Buy257.25704181,104441,675Aug 03 04:54 PM
Rosiello Robert L.EVP, Chief Financial OfficerJul 30Buy253.997,1711,821,362440,971Aug 03 04:54 PM